PCSK1N and major depressive disorder: MDD patients showed significant downregulation in the CSF levels of PCSK1N [201–215] (p < 0.05), NPTXR [234–251] (p < 0.05), and CARTPT [75–90] (p < 0.05) in comparison to the controls.